Collaborative Medicinal Development is a clinical stage company developing novel disease modifying drugs for the treatment of both neurodegenerative diseases and cancer.  They are building a portfolio by both inventing new chemical entities in house and licensing promising leads from third parties.

Pharmaceutical

Collaborative Medicinal Development

Craig Rosenfeld

Kay Noel

Chris Hill

Ken Goldman

The board of directors at Collaborative Medicinal Development has a history of experience in the medical and research field, as well as a variety of different educational backgrounds. This allows them to bring a wealth of knowledge and experience to the company in order to help it grow and succeed.

Board of Directors

About

Team members

Other teams at Collaborative Medicinal Development

Leadership Team

CEO and Executive Team